While Illumina, Inc. (NASDAQ:ILMN) disappointed investors by lowering revenue outlook, Heron Therapeutics Inc (NASDAQ:HRTX) started the week off strong with good news from …
Heron Therapeutics Inc (NASDAQ:HRTX) announced that the U.S.
Cowen’s healthcare analyst Boris Peaker weighed in today on biotech firm Heron Therapeutics Inc (NASDAQ:HRTX), following the company’s fourth-quarter financial results and update on its clinical …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicine that address major unmet medical needs, …
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies – fell nearly 4% this week amid a renewed selloff in …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical …
Heron Therapeutics Inc (NASDAQ:HRTX), a biotechnology company focused on improving the lives of patients by developing best-in-class medicines that address major unmet medical needs, …
Arrowhead Research Corp On September 24, 2015 shares of Arrowhead Research Corp (NASDAQ:ARWR) were up as much as 20% after announcing positive phase …
Analysts and investors alike are anticipating what the future holds for Microbiome-focused company Synthetic Biologics Inc (NYSEMKT:SYN) and biotechnology company Heron Therapeutics Inc (NASDAQ:HRTX) as …